fda warning bpc-157 compounding pharmacies Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Exciting news for peptides coming

Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for fda warning bpc 157 unapproved drug marketing warning letter new Content Analysis of US FDA Letters The FDA's Pharmacy Compounding Advisory Committee is scheduled to meet Thursday and Friday to review some of the controversial, popular peptide injections and discuss whether compounding pharmacies should be able to dispense The FDA is considering allowing compounding pharmacies to make unproven peptidessparking fears around efficacy and safety. Head to the link in our bio for the full story. (Reporting by Victoria Salves.

SKU: 50075417003 · From composequickly.com